SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000032
Filing Date
2021-04-16
Accepted
2021-04-16 06:03:39
Documents
12
Period of Report
2021-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rare-20210412.htm   iXBRL 8-K 40891
  Complete submission text file 0000950170-21-000032.txt   153335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20210412_lab.xml EX-101.LAB 12931
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20210412_pre.xml EX-101.PRE 9590
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20210412.xsd EX-101.SCH 2249
5 EXTRACTED XBRL INSTANCE DOCUMENT rare-20210412_htm.xml XML 4522
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 21830023
SIC: 2834 Pharmaceutical Preparations